Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...

The online health platform Hers has launched a new weight loss membership for GLP-1 treatments. The membership starts at $39 for the first month and then costs $149 per month. Hers offers various ...

Foundayo, a new weight loss pill from Eli Lilly, is the first oral GLP-1 that doesn't require fasting. In clinical trials, people lost an average of 8-25 pounds on the drug. One man who took the pill ...

A first-of-its-kind weight loss pill will become the latest drug to be offered on President Trump's cost comparison platform "Trump Rx," CBS News exclusively learned. Foundayo, a GLP-1 drug, is a ...

If you’re on a weight loss journey, you now have an arsenal of medications at your disposal. And while injectable medications have dominated the space for years, GLP-1 weight loss pills are now on the ...

The U.S. Food and Drug Administration’s approval of Eli Lilly’s once-daily pill orforglipron as a weight loss and obesity treatment this week was the fastest approval of a new medication in decades.

GLP-1 medications are now available as both pills and injections, offering more options for weight loss treatment. The two forms work similarly and have comparable results, but differ in dosing, ...

The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug ...

Many people who use glucagon-like peptide-1 (GLP-1) weight loss drugs are reluctant to keep using their injections or pills indefinitely, especially after reaching their weight loss goals. But ...

If the number on the scale has gone down, it might not be for the reason you want. Most of the time, when you aim to lose weight, you're probably seeking fat loss, or reducing excess body fat to ...

Americans have a brand-new weight-loss option, and it’s a GLP-1 pill developed by Eli Lilly. The Food and Drug Administration on Wednesday approved Foundayo, an oral GLP-1 medication that is expected ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...